Elo Tear 0.3% Eye Drop

Introduction

Elo Tear is a prescription medication that contains the active ingredient Hydroxypropylmethylcellulose. It is commonly used to relieve dryness and discomfort in the eyes.

Uses

Elo Tear is primarily prescribed to treat symptoms of dry eye syndrome, a condition characterized by insufficient tear production or poor tear quality. It helps to lubricate the eyes, relieving discomfort, itching, and redness caused by dryness.

Dosage and Administration

The recommended dosage for Elo Tear is typically one to two drops in each affected eye, three to four times per day. Follow the instructions provided by your healthcare professional. To administer the eye drops, tilt your head back slightly, pull down the lower eyelid to form a pocket, and gently squeeze the prescribed number of drops into the pocket. Then, close your eyes gently for a few seconds to allow the medication to spread evenly.

Mechanism of Action

Hydroxypropylmethylcellulose, the active ingredient in Elo Tear, works by forming a protective film on the surface of the eye. This film helps to retain moisture and lubricate the eye, reducing dryness and discomfort. It also helps to stabilize the tear film, preventing excessive evaporation and maintaining adequate lubrication.

Side Effects

While Elo Tear is generally well-tolerated, it may cause some side effects in rare cases. Common side effects include temporary stinging or burning sensation in the eyes upon application. These effects are usually mild and transient. If you experience any persistent or severe side effects, such as eye pain, vision changes, or signs of an allergic reaction (such as rash, itching, or swelling), seek medical attention immediately.

Drug Interactions

There are currently no known significant drug interactions associated with Elo Tear. However, it is always important to inform your healthcare professional about all medications, including over-the-counter drugs and supplements, that you are taking to ensure there are no potential interactions.

Precautions

Before using Elo Tear, inform your healthcare professional if you have any known allergies or sensitivities to Hydroxypropylmethylcellulose or any other ingredients in the medication. Mention any existing eye conditions or ongoing treatments. Avoid touching the tip of the dropper to any surface, including the eye, to prevent contamination. If you wear contact lenses, remove them before using the eye drops and wait at least 15 minutes before reinserting them.

Storage

Elo Tear should be stored in a cool, dry place away from direct sunlight. Keep the bottle tightly closed when not in use, and do not freeze the medication. Check the expiration date and discard any unused medication after the recommended period.

Patient Tips

• Follow the prescribed dosage and administration instructions provided by your healthcare professional.
• If you wear contact lenses, remove them before using the eye drops and wait at least 15 minutes before reinserting them.
• Avoid touching the tip of the dropper to any surface, including the eye, to prevent contamination.
• If you experience persistent or severe side effects, or if your symptoms do not improve, consult your healthcare professional.
• Store the medication in a cool, dry place and check the expiration date before use.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Generic Solodyn Availability (Drugs.com) [Accessed 25 Jun. 2024] (online) Available at:
• Gullapalli RP, Mazzitelli CL. Gelatin and Non-Gelatin Capsule Dosage Forms. J Pharm Sci. 2017 Jun;106(6):1453-1465. doi: 10.1016/j.xphs.2017.02.006. Epub 2017 Feb 14. [Accessed 15 Jun. 2024] Available at:
• Yu C, Lu Y, Pang J, Li L. A hemostatic sponge derived from chitosan and hydroxypropylmethylcellulose. J Mech Behav Biomed Mater. 2024 Feb;150:106240. doi: 10.1016/j.jmbbm.2023.106240. Epub 2023 Nov 16. [Accessed 1 Jun. 2024] Available at:
• Okubo M, Iohara D, Anraku M, Higashi T, Uekama K, Hirayama F. A thermoresponsive hydrophobically modified hydroxypropylmethylcellulose/cyclodextrin injectable hydrogel for the sustained release of drugs. Int J Pharm. 2020 Feb 15;575:118845. doi: 10.1016/j.ijpharm.2019.118845. Epub 2019 Dec 10. [Accessed 17 Jun. 2024] Available at: